NCT02473211View on ClinicalTrials.gov

SOF Plus DCV in Treating Chinese Treatment-experienced HCV Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

March 15, 2018

Conditions
Chronic Hepatitis C Infection
Interventions
DRUG

Sofosbuvir

Sofosbuvir 400 mg tablet administered once daily

DRUG

Daclatasvir

Daclatasvir 60mg tablet administered once daily

Trial Locations (2)

100039

Liver Fibrosis Diagnosis and Treatment Centre, 302 Hospital, Beijing

00852

Humanity and Health GI and Liver Centre, Hong Kong

All Listed Sponsors
collaborator

Beijing 302 Hospital

OTHER

lead

Humanity and Health Research Centre

OTHER

NCT02473211 - SOF Plus DCV in Treating Chinese Treatment-experienced HCV Patients | Biotech Hunter | Biotech Hunter